Home ver. 2.3. site index contact us      
logo  
 
Click here to know more about our corporation. Click here to know more about our products. Click here to know more about our research and development initiatives. Click here to explore partnership opportunities with us. Click here to know more about recent news and happenings. Click here to know more about the financial details. Click here to know more about our coporate responsibility intiatives. Click here to explore the career opportunities with us.
 
 
About Us
Message from the
President & MD
How We Work
Management Team
 
Home > About Us > Message from the President & MD
 
Message from the President & MD
A Message From President & MD
Mr. K.G. Ananthakrishnan
 

It is my pleasure to welcome you to the world of Fulford.

As a leading healthcare company, our focus is  To Earn Trust, Every Day.

We aspire to earn the trust of doctors, patients, customers and other stakeholders as a champion for them and as a company that provides them with a steady flow of science-based medicines and services.

By earning trust, we will build growth.

Being a part of Schering-Plough gives us a global footprint and an opportunity to serve our customers with world-class products and services. Schering-Plough’s new combination with Organon BioSciences further strengthens our position in India. I have the privilege to lead the executive management team responsible for Fulford and Organon, the two units of Schering-Plough’s global pharmaceutical business in India.

 

Currently, we occupy a unique position in our industry with our range of high science-based product portfolio and we are aiming to provide state of the art products and services in order to attain market leadership.

 

We are proud to have an excellent portfolio of products in Mass and Specialty segments which have a great potential for growth. We now have the opportunity to strengthen this combined portfolio with the introduction of global brands, as well as by maximizing other potential local opportunities to gain leadership.

 

Internationally, Schering-Plough has been building a new kind of healthcare company. Throughout Schering-Plough, there is a desire to build long-term relationships with stakeholders based on mutual confidence. Schering-Plough is committed to earning the trust of doctors, patients and customers everyday. And we continue to listen and learn and aim to become an organization that strives to build and nourish trust in our chosen areas of specialization. For us, that means working to truly get in tune with our stakeholders.

 

While we are increasing the pace of our growth, the way we work remains rooted in our Leader Behavior.

 
Leader Behaviors

  • Shared accountability and transparency
  • Cross functional teamwork and collaboration
  • Listening and learning
  • Benchmarking and continuously improving
  • Coaching and developing others
  • Business integrity

 By continuously developing and measuring ourselves against these Leader Behaviors, we will foster innovation, speed and flexibility that drive results and help us to live up to our Vision - “To Earn Trust, Every Day”.  We believe that by exhibiting our Leader Behavior, we will develop the Leadership Edge. This Leadership Edge will make our company a high-performance driven organization for the long term.
                                                                   

K.G. Ananthakrishnan
President and Managing Director

 
 

 

 

 
Spotlight On
 
     
 
 
     
 
     
 
Basic facts & figures
 

 

 
 

India Headquarters:
Eureka Towers, 8th Floor, B-wing,Mindspace, Link Road, Malad (West)
Mumbai 400 064
India

 

President and MD: Mr. K.G. Ananthakrishnan

 

Number of Employees: about 450

Largest-selling product:Quadriderm RF Cream

Web Site Address: www.fulfordindia.com

Stock Exchange Listings: Bombay Stock Exchange (BSE)

Key Products: Quadriderm RF, Dipsalic F, Elocon, Alaspan, Netromyicin
Remicade, Viraferon Peg, Integrilin